The FDA approved BioSante Pharmaceuticals (Nasdaq: BPAX ) Bio-T-Gel yesterday. Shares were up 61% at one point this morning which I guess is somewhat justified but its still trading at less than half the level it was before LibiGel failed in December. Both drugs deliver testosterone to people ...

guest published in:02-22   reply:0   view:21    last updated:02-22 19:29( guest )